The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Letter/Comment
Recent Guidance on Meaningful Use of EHRs Makes Compliance More Difficult.
White Papers
A recap of the Executive Thought Leader Forum hosted by AHRMM on August 6, 2012, to discuss the transforming healthcare environment.
Request for Proposals (RFP)
A sample of wholesale pharmacy distributor request for proposal.
Guides/Reports
In 2001 the Institute of Medicine (IOM) published
Advisory
The Food and Drug Administration (FDA) UDI system is being phased in over several years.